Tel.: +34 91 736 2385
LOCAL TIME
Contact: Katarina Gluic
Hours: Mon-Thu 8:30-17:00 Fri 8:30-15:00
13:30
For help with a poster, please specify the poster number, the first author and the congress and we will reply shortly.
Poster no.
Contact name
E-mail
Telephone
Congress
Comments

 

WFH 2016 World Congress

 

24-28 July 2016 Orlando
FAQs
   
Discussion forum - WFH 2016 World Congress
    Topic - Novel therapeutic agents

If you are already registered in PosterSessionOnline, enter your e-mail and click on LOGIN. Otherwise click on REGISTER
  
 Thread / Poster  Author  Replies  Last reply
Increasing the in vivo half-life of factor VIIa by attachment of the natural polysaccharide heparosan  Jesper Haaning 1      7/21/2016 1:45:00 PM  
Interaction of BAX 826 (PSAylated rFVIII) with VWF and LRP1 An in vitro and in vivo assessment  Michael Dockal 1      7/19/2016 4:28:00 PM  
Clinical and laboratorial evaluation of recombinant FVIII Fc fusion protein treatment in hemophilia A patients: a real-life in a single center  MARION ECHENAGUCIA 1      7/7/2016 9:07:00 PM  
Structural and functional characterization of preclinical and clinical batches of BAX 826, a PSAylated full-length recombinant FVIII  Michael Dockal 1      7/6/2016 2:20:00 PM  
Factor VIIa-CTP , a novel FVIIa potentially supporting subcutaneous treatment - comprehensive assessment in Hemophilic animals models in preparation for first in human study.  Gili Hart 1      7/5/2016 10:57:00 AM  
In-vitro Evaluation of Factor VIIa-CTP, a Novel Long-Acting Coagulation Factor  Gili Hart 1      7/5/2016 10:29:00 AM  
FVIIa-CTP, a novel long acting FVIIa, Comprehensive Pharmacokinetics and Pharmacodynamics and Bioavailability evaluation following Subcutaneous (SC) and Intravenous (IV) administration to hemophilic animal models.  Gili Hart 1      7/5/2016 9:30:00 AM  
       




Most viewed poster for this congress
Poster: 13
Visits: 590
Title: Algorithmic evidence-based phenotype screening and collaborative approach to attacking symptoms of nonadherence in patients with bleeding disorders
Authors: Jay Bryant-Wimp , Jay Bryant-Wimp, RPh
Centre: Integrite Solutions

Poster most viewed in this topic
Poster: 98
Visits: 72
Title: Factor VIIa-CTP , a novel FVIIa potentially supporting subcutaneous treatment - comprehensive assessment in Hemophilic animals models in preparation for first in human study.
Authors: Gili Hart ,
Centre: OPKO Biologics


 






PosterSessionOnline
Logo Draft
 
Logo Cert